Dyne Therapeutics, Inc. · NASDAQ:DYN

Rhodes Jason P sold 227,337 Dyne Therapeutics, Inc. shares (Form 4)

Traded Apr 28, 2026 · Filed Apr 30, 2026

On Apr 28, 2026, Rhodes Jason P (Director) sold 227,337 Dyne Therapeutics, Inc. shares at an average US$18.38 for US$4.18M under a trading plan, leaving 1,158,923 shares. Filed Apr 30, 2026 (Form 4).

Sold
227,337 shares
Price
US$18.38 average (US$18.38 to US$19.00)
Value
US$4.18M
Holding after
1,158,923 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 28, 2026Common StockSale59,870US$18.381,577,432Indirect
Apr 28, 2026Common StockSale119,115US$18.384,939,489Indirect
Apr 28, 2026Common StockSale1,170US$18.388,512Indirect
Apr 28, 2026Common StockSale47,082US$18.381,158,944Indirect
Apr 28, 2026Common StockSale26US$19.001,577,406Indirect
Apr 28, 2026Common StockSale52US$19.004,939,437Indirect
Apr 28, 2026Common StockSale1US$19.008,511Indirect
Apr 28, 2026Common StockSale21US$19.001,158,923Indirect

Source

View original at SEC

Related